HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Alourfi, Z Articles by Ray, D W Search for Related Content PubMed PubMed Citation Articles by Alourfi, Z Articles by Ray, D W

¹ ARC Epidemiology Unit,
² Endocrine Sciences Research Group, and
³ Centre for Molecular Medicine, Faculty of Medicine, University of Manchester, Manchester M13 9PT, UK

(Requests for offprints should be addressed to D W Ray, Endocrine Sciences Research Group, Stopford Building, University of Manchester, Manchester M13 9PT, UK; Email David.W.Ray{at}man.ac.uk)

MIF is a potent proinflammatory cytokine involved in inflammatory arthritis. Glucocorticoids (GC) have been reported to induce secretion of MIF in rodent cells, and as MIF counteracts the anti-inflammatory effects of GC, this has implications for human inflammatory disease. Transient transfection studies showed that the MIF promoter was repressed by dexamethasone (Dex) (10 nM) in CEM C7A cells, with up to 50% suppression by 100 nM. However, there was no regulation of the promoter by GC in A549 cells. We also found that subnanomolar concentrations of Dex suppressed MIF secretion, measured by ELISA, by 80% in both human T lymphoblasts (CEM C7A) and human lung epithelial cells (A549). Endogenous MIF mRNA was also repressed by GC in CEM C7A cells, measured both by Northern blot and quantitative RT-PCR assays, but there was no such regulation in A549 cells. This suggests that GC affects translation rather than transcription of MIF in A549 cells. These results contradict earlier results with the rat cell line RAW 264.7. Therefore, we analysed MIF secretion from RAW 264.7 cells but found no GC effect on secretion. Understanding how GC regulates MIF in a cell-type-dependent manner may give insights into GC-refractory human inflammatory diseases.

This article has been cited by other articles:

				L. Rice, C. E Waters, J. Eccles, H. Garside, P. Sommer, P. Kay, F. H Blackhall, L. Zeef, B. Telfer, I. Stratford, et al. Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor J. Endocrinol., September 1, 2008; 198(3): 499 - 509. [Abstract] [Full Text] [PDF]

				L. Matthews, A. Berry, V. Ohanian, J. Ohanian, H. Garside, and D. Ray Caveolin Mediates Rapid Glucocorticoid Effects and Couples Glucocorticoid Action to the Antiproliferative Program Mol. Endocrinol., June 1, 2008; 22(6): 1320 - 1330. [Abstract] [Full Text] [PDF]

				R. Perveen, J. Favor, R.V. Jamieson, D.W. Ray, and G.C.M. Black A heterozygous c-Maf transactivation domain mutation causes congenital cataract and enhances target gene activation Hum. Mol. Genet., May 1, 2007; 16(9): 1030 - 1038. [Abstract] [Full Text] [PDF]

				G. A. Awandare, Y. Ouma, C. Ouma, T. Were, R. Otieno, C. C. Keller, G. C. Davenport, J. B. Hittner, J. Vulule, R. Ferrell, et al. Role of Monocyte-Acquired Hemozoin in Suppression of Macrophage Migration Inhibitory Factor in Children with Severe Malarial Anemia Infect. Immun., January 1, 2007; 75(1): 201 - 210. [Abstract] [Full Text] [PDF]